• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • NORTH AMERICA EDITION
      Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • NORTH AMERICA EDITION
      North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Life Science Market
    Life Science News
    Life Science Stocks
    • Life Science Market
    • Life Science News
    • Life Science Stocks
    life science investing

    Antidepressants Linked to Lower Heart Disease

    Charlotte McLeod
    Mar. 09, 2015 04:13PM PST
    Life Science Investing News

    According to a Science World Report article, a new study indicates that patients treated with antidepressants have lower lower mortality rates, as well as lower stroke and artery disease when compared to patients not treated with such medication.

    According to a Science World Report article, a new study indicates that patients treated with antidepressants have lower lower mortality rates, as well as lower stroke and artery disease when compared to patients not treated with such medication.

    As quoted in the market news:

    The study, based on three years of research, involved about 5,311 people who were affected by severe depression out of over 26,000 patients who were treated at the involved medical facility. The results showed that 20 percent had moderate or severe depression while the remaining 21,517 patients didn’t show depression based on a 9-question depression screen.

    Heidi May, the lead author of the study and a public health scientist, commented:

    This study demonstrates the importance of evaluating patients for depression,not only in terms of improving their mood, but reducing their risk for heartdisease.

    Antidepressants were not associated with a reduced cardiovascular risk in people with little or no depression, but in moderately to severely depressed people, antidepressants were shown to significantly improve cardiovascular outcomes. We thought we’d see an additive effect.

    Click here to read the full Science World Report article.

    life science investing
    The Conversation (0)

    Go Deeper

    AI Powered
    Johnson & Johnson to showcase industry-leading neuropsychiatry innovations at the 2025 Psych Congress Annual Meeting

    Johnson & Johnson to showcase industry-leading neuropsychiatry innovations at the 2025 Psych Congress Annual Meeting

    Emyria Limited

    Emyria and UWA in Partnership to Commercialise Novel Serotonin-Releasing Agents for Mental Health and Neurology

    Latest News

    Lobe Sciences Ltd. to Attend the ArcStone-Kingswood Growth Summit 2025 in Toronto

    More News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Life Science Investing News Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES